BioWorld

May 18, 2005

View Archived Issues

Lexicon, Organon Enter $73M Protein, Antibody Agreement

Signing its fourth major drug discovery alliance, Lexicon Genetics Inc. formed a $72.5 million collaboration with NV Organon to find five drug candidates for inflammatory disease. (BioWorld Today) Read More

NovImmune, Serono Enter Antibody Deal Worth $122M

Read More

Amgen, Abgenix Offer Strong Phase II Panitumumab Results

Read More

Licensing Deal Gives Spectrum Radiation Adjunct For Cancer

Read More

Other News To Note

Read More